[9-(2-acetyloxybenzoyl)oxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] 2-acetyloxybenzoate

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: [9-(2-acetyloxybenzoyl)oxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] 2-acetyloxybenzoate
• 化学式: C₃₅H₃₁NO₉
• 分子量: 609.6
• InChiKey: XPLFWDWDCNJVCV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  45
• 可旋转键数：
  10
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  118
• 氢给体数：
  0
• 氢受体数：
  10

文献信息

• [EN] IMMEDIATE-RELEASE ABUSE DETERRENT COMPOSITIONS OR MEDICAMENTS FOR TREATING PAIN, ADD, ADHD AND OTHER SYNDROMES OR DISORDERS<br/>[FR] COMPOSITIONS ANTI-ABUS À LIBÉRATION IMMÉDIATE OU MÉDICAMENTS DESTINÉS AU TRAITEMENT DE LA DOULEUR, DU DCA, DU TDAH, ET D'AUTRES SYNDROMES OU TROUBLES
  申请人：KEMPHARM INC

  公开号：WO2018071879A1

  公开（公告）日：2018-04-19

  The presently described technology provides one or more compositions, preferably one or more immediate-release profile compositions, comprising aryl carboxylic acids chemically conjugated to hydrocodone (morphinan-6-one, 4,5- alpha-epoxy-3-methoxy-17-methyl), or chemically conjugated to hydromorphone (4,5,α-epoxy-3-hydroxy-17-methyl morphinan-6-one), in combination with at least one gel forming polymer; at least one disintegrant; and at least one surfactant to form novel compositions which have a decreased potential for abuse. The hydrocodone conjugate can also be combined with an analgesic, such as acetaminophen, to form a combinatorial composition that includes at least one gel forming polymer; at least one disintegrant; and at least one surfactant. The present technology also provides pharmaceutical kits and methods of synthesizing conjugates of the present technology.

  目前描述的技术提供了一种或多种组合物，最好是一种或多种立即释放剖面组合物，其中含有与羟考酮（吗啡-6-酮，4,5-α-环氧-3-甲氧基-17-甲基）或与羟吗啡（4,5,α-环氧-3-羟基-17-甲基吗啡-6-酮）化学结合的芳基羧酸，结合至少一种凝胶形成聚合物；至少一种崩解剂；和至少一种表面活性剂，以形成具有减少滥用潜力的新型组合物。羟考酮结合物还可以与镇痛剂（如对乙酰氨基酚）结合，形成包括至少一种凝胶形成聚合物；至少一种崩解剂；和至少一种表面活性剂的组合物。该技术还提供了药物配套组和合成本技术结合物的方法。
• IMMEDIATE-RELEASE ABUSE DETERRENT COMPOSITIONS OR MEDICAMENTS FOR TREATING PAIN, ADD, ADHD AND OTHER SYNDROMES OR DISORDERS
  申请人：KEMPHARM, INC.

  公开号：US20200038383A1

  公开（公告）日：2020-02-06

  The presently described technology provides one or more compositions, preferably one or more immediate-release profile compositions, comprising aryl carboxylic acids chemically conjugated to hydrocodone (morphinan-6-one, 4,5-alpha-epoxy-3-methoxy-17-methyl), or chemically conjugated to hydromorphone (4,5,α-epoxy-3-hydroxy-17-methyl morphinan-6-one), in combination with at least one gel forming polymer; at least one disintegrant; and at least one surfactant to form novel compositions which have a decreased potential for abuse. The hydrocodone conjugate can also be combined with an analgesic, such as acetaminophen, to form a combinatorial composition that includes at least one gel forming polymer; at least one disintegrant; and at least one surfactant. The present technology also provides pharmaceutical kits and methods of synthesizing conjugates of the present technology.